{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:13:00Z","timestamp":1793506380512,"version":"4.5.0"},"reference-count":284,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127070"],"award-info":[{"award-number":["R01AI127070"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA210273"],"award-info":[{"award-number":["R01CA210273"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE030691"],"award-info":[{"award-number":["R01DE030691"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK125087"],"award-info":[{"award-number":["R01DK125087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS122536"],"award-info":[{"award-number":["R01NS122536"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA210152"],"award-info":[{"award-number":["U01CA210152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021R1F1A106212711"],"award-info":[{"award-number":["2021R1F1A106212711"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.addr.2021.114021","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T18:31:55Z","timestamp":1635273115000},"page":"114021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"special_numbering":"C","title":["Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-9698","authenticated-orcid":false,"given":"Yonghyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-4178","authenticated-orcid":false,"given":"Nobuhiko","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.114021_b0005","doi-asserted-by":"crossref","unstructured":"R. Pabst, M.W. Russell, P. Brandtzaeg, Tissue distribution of lymphocytes and plasma cells and the role of the gut, Trends Immunol, 29 (2008) 206-208; author reply 209-210.","DOI":"10.1016\/j.it.2008.02.006"},{"key":"10.1016\/j.addr.2021.114021_b0010","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1373208","article-title":"Intestinal barrier and gut microbiota: Shaping our immune responses throughout life","volume":"5","author":"Takiishi","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.addr.2021.114021_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805007","article-title":"Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis","volume":"30","author":"Song","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2021.114021_b0020","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.114021_b0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.aat0835","article-title":"Intestinal barriers protect against disease","volume":"359","author":"Citi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0045","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1586\/14760584.2014.936852","article-title":"Oral delivery of nanoparticle-based vaccines","volume":"13","author":"Marasini","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.addr.2021.114021_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","article-title":"Current state and challenges in developing oral vaccines","volume":"114","author":"Vela Ramirez","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mi.2012.4","article-title":"Oral tolerance to food protein","volume":"5","author":"Pabst","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0060","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acsnano.0c07258","article-title":"Implications of the Human Gut-Brain and Gut-Cancer Axes for Future Nanomedicine","volume":"14","author":"Javed","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.114021_b0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0884533615609899","article-title":"Gut Microbiome: What We Do and Don't Know","volume":"30","author":"Cresci","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.addr.2021.114021_b0070","first-page":"603","article-title":"Nanoparticles for mucosal vaccine delivery, Nanoengineered Biomaterials for Advanced","author":"Thakur","year":"2020","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2021.114021_b0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/erv.11.196","article-title":"Novel vaccine development strategies for inducing mucosal immunity","volume":"11","author":"Fujkuyama","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.addr.2021.114021_b0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-3083.2009.02319.x","article-title":"Mucosal immunity: induction, dissemination, and effector functions","volume":"70","author":"Brandtzaeg","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1189\/jlb.0307144","article-title":"The impact of cell-bound antigen transport on mucosal tolerance induction","volume":"82","author":"Pabst","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2021.114021_b0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gut.2006.098160","article-title":"Comparative study of the intestinal mucus barrier in normal and inflamed colon","volume":"56","author":"Swidsinski","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0100","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.addr.2012.10.013","article-title":"Mechanism of oral tolerance induction to therapeutic proteins","volume":"65","author":"Wang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0110","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.addr.2021.114021_b0115","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.114021_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.114021_b0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2015.03.033","article-title":"Gut microbiota: the link to your second brain","volume":"161","author":"Ridaura","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.addr.2021.114021_b0130","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jps.23082","article-title":"N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties","volume":"101","author":"Lee","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2021.114021_b0135","first-page":"4105","article-title":"Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery","volume":"9","author":"Lee","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.addr.2021.114021_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2021.114021_b0145","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/apt.14688","article-title":"Systematic review: safety of mesalazine in ulcerative colitis","volume":"47","author":"Sehgal","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2021.114021_b0150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijpharm.2014.10.059","article-title":"Administration strategies for proteins and peptides","volume":"477","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.114021_b0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nantod.2017.08.006","article-title":"Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2021.114021_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.114021_b0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2021.114021_b0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0180","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.114021_b0185","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2011.02.012","article-title":"Interactions between the host innate immune system and microbes in inflammatory bowel disease","volume":"140","author":"Abraham","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/579650","article-title":"Innate immune sensors and gastrointestinal bacterial infections","volume":"2011","author":"Hold","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.addr.2021.114021_b0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12192","article-title":"Macrophages in intestinal homeostasis and inflammation","volume":"260","author":"Bain","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/mi.2012.89","article-title":"Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors","volume":"6","author":"Bain","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1126\/science.1102901","article-title":"CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance","volume":"307","author":"Niess","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm.3189","article-title":"Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection","volume":"19","author":"Grainger","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.114021_b0215","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/mi.2012.24","article-title":"The role of neutrophils during intestinal inflammation","volume":"5","author":"Fournier","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12968\/jowc.2003.12.1.26458","article-title":"The role of neutrophil apoptosis in influencing tissue repair","volume":"12","author":"Sylvia","year":"2003","journal-title":"J Wound Care"},{"key":"10.1016\/j.addr.2021.114021_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0230","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fimmu.2019.00961","article-title":"Human Gut-Associated Natural Killer Cells in Health and Disease","volume":"10","author":"Poggi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-12-809954-4.00027-X","article-title":"Gut Barrier: Innate Immunity","author":"den Hartog","year":"2018","journal-title":"Physiology of the Gastrointestinal Tract"},{"key":"10.1016\/j.addr.2021.114021_b0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11894-016-0522-0","article-title":"Next-Generation Therapeutics for Inflammatory Bowel Disease","volume":"18","author":"Dulai","year":"2016","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.addr.2021.114021_b0245","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.it.2004.09.005","article-title":"Let's go mucosal: communication on slippery ground","volume":"25","author":"Brandtzaeg","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"issue":"173\u2013184","key":"10.1016\/j.addr.2021.114021_b0255","first-page":"e171","article-title":"Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's patch dendritic cells that express lysozyme","volume":"138","author":"Lelouard","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b0260","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.addr.2021.114021_b0265","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1073\/pnas.061412598","article-title":"Peyer's patches are required for oral tolerance to proteins","volume":"98","author":"Fujihashi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2021.114021_b0270","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A","article-title":"Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches","volume":"31","author":"Spahn","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0275","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1521-4141(200204)32:4<1109::AID-IMMU1109>3.0.CO;2-K","article-title":"Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches","volume":"32","author":"Spahn","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0280","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/mi.2009.127","article-title":"Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa","volume":"3","author":"Strbo","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2021.114021_b0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mi.2010.5","article-title":"Multiple facets of intestinal permeability and epithelial handling of dietary antigens","volume":"3","author":"Menard","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0300","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I","article-title":"\u201cTolerosomes\u201d are produced by intestinal epithelial cells","volume":"31","author":"Karlsson","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20052016","article-title":"Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells","volume":"203","author":"Worbs","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2021.114021_b0310","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","article-title":"Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid","volume":"204","author":"Sun","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2021.114021_b0315","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.immuni.2011.01.016","article-title":"Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria","volume":"34","author":"Hadis","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b0325","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0330","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI40926","article-title":"Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice","volume":"120","author":"Tomura","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2021.114021_b0335","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0038-1646949","article-title":"Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease","volume":"38","author":"Dou","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.addr.2021.114021_b0340","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0345","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","article-title":"Plasmacytoid dendritic cells mediate oral tolerance","volume":"29","author":"Goubier","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0355","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.addr.2011.07.003","article-title":"Gut-associated lymphoid tissues for the development of oral vaccines","volume":"64","author":"Kunisawa","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0360","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0370","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.addr.2021.114021_b0375","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b0380","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.jmb.2016.02.010","article-title":"The Densely O-Glycosylated MUC2 Mucin Protects the Intestine and Provides Food for the Commensal Bacteria","volume":"428","author":"Arike","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2021.114021_b0385","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpg.2013.03.001","article-title":"Glycobiome: bacteria and mucus at the epithelial interface","volume":"27","author":"Ouwerkerk","year":"2013","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2021.114021_b0390","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/glycob\/cwt045","article-title":"Mucin-type O-glycans and their roles in intestinal homeostasis","volume":"23","author":"Bergstrom","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.addr.2021.114021_b0395","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1038\/ncomms9292","article-title":"The outer mucus layer hosts a distinct intestinal microbial niche","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.114021_b0400","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/femsre\/fuz013","article-title":"Experimental models to study intestinal microbes-mucus interactions in health and disease","volume":"43","author":"Etienne-Mesmin","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0405","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","article-title":"Mucins and the Microbiome","volume":"89","author":"Hansson","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2021.114021_b0410","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/febs.15504","article-title":"Home, sweet home: how mucus accommodates our microbiota","volume":"288","author":"Wang","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.addr.2021.114021_b0415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S0007114516004037","article-title":"Can probiotics modulate human disease by impacting intestinal barrier function?","volume":"117","author":"Bron","year":"2017","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.addr.2021.114021_b0420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fcimb.2017.00387","article-title":"Interactions of Intestinal Bacteria with Components of the Intestinal Mucus","volume":"7","author":"Sicard","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2017.11.004","article-title":"Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration","volume":"23","author":"Schroeder","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2021.114021_b0430","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/apha.12695","article-title":"Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice","volume":"217","author":"Ahl","year":"2016","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.addr.2021.114021_b0435","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2021.114021_b0440","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b0445","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3389\/fmicb.2017.01804","article-title":"Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0450","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12979-019-0145-z","article-title":"Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1 (-\/Delta7) mice","volume":"16","author":"van der Lugt","year":"2019","journal-title":"Immun Ageing"},{"key":"10.1016\/j.addr.2021.114021_b0455","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41591-019-0504-5","article-title":"Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice","volume":"25","author":"Barcena","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.114021_b0460","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.114021_b0465","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0470","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.addr.2021.114021_b0475","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: from simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2021.114021_b0480","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.physiol.68.040104.131404","article-title":"Claudins and epithelial paracellular transport","volume":"68","author":"Van Itallie","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.addr.2021.114021_b0485","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.addr.2021.114021_b0490","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1053\/j.gastro.2016.07.008","article-title":"Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair","volume":"151","author":"Luissint","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b0495","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.aan0814","article-title":"C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions","volume":"359","author":"Mohanan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0500","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0505","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0510","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/immunohorizons.1800027","article-title":"Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability","volume":"2","author":"Manzanillo","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.addr.2021.114021_b0515","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/gastro\/goz056","article-title":"Association of polymorphisms in C1orf106, IL1RN, and IL10 with post-induction infliximab trough level in Crohn's disease patients","volume":"8","author":"Tang","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.addr.2021.114021_b0520","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-065X.2011.01078.x","article-title":"Epithelial barrier: an interface for the cross-communication between gut flora and immune system","volume":"245","author":"Goto","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b0525","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.addr.2021.114021_b0530","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.addr.2021.114021_b0535","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.chom.2015.10.007","article-title":"Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial Colonization","volume":"18","author":"Johansson","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2021.114021_b0540","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/gastro\/goy052","article-title":"Fight them or feed them: how the intestinal mucus layer manages the gut microbiota","volume":"7","author":"Schroeder","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.addr.2021.114021_b0545","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.273.5280.1380","article-title":"A model of host-microbial interactions in an open mammalian ecosystem","volume":"273","author":"Bry","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0550","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fimmu.2019.00607","article-title":"Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens","volume":"10","author":"Cheng","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0560","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1542\/peds.2013-3937","article-title":"Stool microbiota and vaccine responses of infants","volume":"134","author":"Huda","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.addr.2021.114021_b0565","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.immuni.2014.08.009","article-title":"TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination","volume":"41","author":"Oh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b0570","doi-asserted-by":"crossref","first-page":"e01021","DOI":"10.1128\/mBio.01021-14","article-title":"Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls","volume":"5","author":"Schubert","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.addr.2021.114021_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anaerobe.2015.03.008","article-title":"Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization","volume":"34","author":"Zhang","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.addr.2021.114021_b0580","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.anaerobe.2016.05.003","article-title":"Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract","volume":"41","author":"Winston","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.addr.2021.114021_b0585","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","article-title":"Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis","volume":"183","author":"Ochoa-Reparaz","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0590","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2021.114021_b0595","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1056\/NEJMc1803103","article-title":"Fecal Microbiota Transplantation for Primary Clostridium difficile Infection","volume":"378","author":"Juul","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2021.114021_b0600","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3892\/etm.2012.718","article-title":"Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease","volume":"4","author":"Wang","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.addr.2021.114021_b0605","doi-asserted-by":"crossref","unstructured":"P. Moayyedi, M.G. Surette, P.T. Kim, J. Libertucci, M. Wolfe, C. Onischi, D. Armstrong, J.K. Marshall, Z. Kassam, W. Reinisch, C.H. Lee, Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial, Gastroenterology, 149 (2015) 102-109 e106.","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"10.1016\/j.addr.2021.114021_b0610","doi-asserted-by":"crossref","unstructured":"N.G. Rossen, S. Fuentes, M.J. van der Spek, J.G. Tijssen, J.H. Hartman, A. Duflou, M. Lowenberg, G.R. van den Brink, E.M. Mathus-Vliegen, W.M. de Vos, E.G. Zoetendal, G.R. D'Haens, C.Y. Ponsioen, Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis, Gastroenterology, 149 (2015) 110-118 e114.","DOI":"10.1053\/j.gastro.2015.03.045"},{"key":"10.1016\/j.addr.2021.114021_b0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.14173","article-title":"Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis","volume":"46","author":"Costello","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2021.114021_b0620","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5217\/ir.2017.15.2.244","article-title":"Fecal microbiota transplantation for refractory Crohn's disease","volume":"15","author":"Bak","year":"2017","journal-title":"Intest Res"},{"key":"10.1016\/j.addr.2021.114021_b0625","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","article-title":"Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial","volume":"36","author":"Kouchaki","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.addr.2021.114021_b0630","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2021.114021_b0635","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000459","article-title":"Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS","volume":"5","author":"Makkawi","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.addr.2021.114021_b0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091887","article-title":"Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer","volume":"18","author":"Di Domenico","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.114021_b0645","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jcp.2004.018556","article-title":"Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma","volume":"57","author":"Huang","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.addr.2021.114021_b0650","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2021.114021_b0655","first-page":"S6","article-title":"Helicobacter pylori and gastric cancer: a state of the art review","volume":"8","author":"Ishaq","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.addr.2021.114021_b0660","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b0665","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1038\/nmicrobiol.2017.8","article-title":"Carcinogenesis and therapeutics: the microbiota perspective","volume":"2","author":"Tsilimigras","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171602","article-title":"Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia","volume":"12","author":"Purcell","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.114021_b0675","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/ciu787","article-title":"The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients","volume":"60","author":"Boleij","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2021.114021_b0680","doi-asserted-by":"crossref","first-page":"E1820","DOI":"10.1073\/pnas.1207829109","article-title":"Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer","volume":"109","author":"Mangerich","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2021.114021_b0685","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gr.126516.111","article-title":"Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma","volume":"22","author":"Castellarin","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.addr.2021.114021_b0690","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2021.114021_b0695","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0700","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/gutjnl-2018-317200","article-title":"Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin","volume":"68","author":"He","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b0705","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2017.05.001","article-title":"The microbiome and hepatobiliary-pancreatic cancers","volume":"402","author":"Mima","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2021.114021_b0710","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1099\/jmm.0.000371","article-title":"Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle","volume":"65","author":"Garcia-Castillo","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b0715","article-title":"Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions","volume":"10","author":"Tiso","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.114021_b0720","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.addr.2021.114021_b0725","article-title":"The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer","volume":"108","author":"Kwa","year":"2016","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.addr.2021.114021_b0730","article-title":"Evolving concepts: how diet and the intestinal microbiome act as modulators of breast malignancy","volume":"2013","author":"Shapira","year":"2013","journal-title":"ISRN Oncol"},{"key":"10.1016\/j.addr.2021.114021_b0735","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/0008-5472.CAN-10-2833","article-title":"LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis","volume":"71","author":"Hsu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2021.114021_b0740","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","article-title":"The gut microbiome and liver cancer: mechanisms and clinical translation","volume":"14","author":"Yu","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2021.114021_b0745","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0750","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0755","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0760","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.114021_b0765","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","article-title":"Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer","volume":"29","author":"Derosa","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2021.114021_b0770","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0775","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0780","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0785","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020193","article-title":"Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function","volume":"8","author":"Schoultz","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.addr.2021.114021_b0795","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI122085","article-title":"Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing","volume":"129","author":"Butin-Israeli","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2021.114021_b0800","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1073\/pnas.83.8.2501","article-title":"Identification of the macrophage mannose receptor as a 175-kDa membrane protein","volume":"83","author":"Wileman","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2021.114021_b0805","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2007.10.010","article-title":"Sweet preferences of MGL: carbohydrate specificity and function","volume":"29","author":"van Vliet","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2021.114021_b0810","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.114021_b0815","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.biomaterials.2013.01.079","article-title":"Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.114021_b0820","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2014.04.046","article-title":"Fab'-bearing siRNA TNFalpha-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis","volume":"186","author":"Laroui","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.114021_b0825","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MIB.0000000000000677","article-title":"Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics","volume":"22","author":"Dearling","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.addr.2021.114021_b0830","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.114021_b0835","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nbt0408-403","article-title":"siRNAs with guts","volume":"26","author":"Maclachlan","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2021.114021_b0840","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1126\/science.1149859","article-title":"Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target","volume":"319","author":"Peer","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b0845","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2019.10.001","article-title":"Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target","volume":"313","author":"Veiga","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.114021_b0850","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5186","article-title":"Identification of exosome-like nanoparticle-derived microRNAs from 11 edible fruits and vegetables","volume":"6","author":"Xiao","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.addr.2021.114021_b0855","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1039\/C7TB03207B","article-title":"Advances in Plant-derived Edible Nanoparticle-based lipid Nano-drug Delivery Systems as Therapeutic Nanomedicines","volume":"6","author":"Yang","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2021.114021_b0860","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2013.190","article-title":"Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit","volume":"22","author":"Wang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.114021_b0865","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/cr.2011.196","article-title":"Immunosuppressive exosomes from TGF-beta1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells","volume":"22","author":"Cai","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.addr.2021.114021_b0870","doi-asserted-by":"crossref","first-page":"440","DOI":"10.15283\/ijsc18139","article-title":"Immunosuppressive Effect of Exosomes from Mesenchymal Stromal Cells in Defined Medium on Experimental Colitis","volume":"12","author":"Ma","year":"2019","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.addr.2021.114021_b0875","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.3390\/nu7085271","article-title":"Immune Modulation by Vitamin D and Its Relevance to Food Allergy","volume":"7","author":"Suaini","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.addr.2021.114021_b0880","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s40629-018-0054-2","article-title":"Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease","volume":"27","author":"Hufnagl","year":"2018","journal-title":"Allergo J Int"},{"key":"10.1016\/j.addr.2021.114021_b0885","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1538-7836.2010.04116.x","article-title":"Repeated oral administration of chitosan\/DNA nanoparticles delivers functional FVIII with the absence of antibodies in hemophilia A mice","volume":"8","author":"Dhadwar","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.addr.2021.114021_b0890","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.10198","article-title":"Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance","volume":"46","author":"Kim","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2021.114021_b0895","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1073\/pnas.0503428102","article-title":"A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses","volume":"102","author":"Takagi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2021.114021_b0900","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1467-7652.2011.00613.x","article-title":"Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression","volume":"9","author":"Suzuki","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2021.114021_b0905","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.cji.0000171315.82997.9a","article-title":"Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens","volume":"28","author":"Denes","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.addr.2021.114021_b0910","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI24970","article-title":"Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo","volume":"115","author":"Clayburgh","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2021.114021_b0915","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejpb.2017.07.004","article-title":"Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model","volume":"119","author":"Melero","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2021.114021_b0920","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.copbio.2018.03.010","article-title":"Selective permeability of mucus barriers","volume":"52","author":"Witten","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2021.114021_b0925","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/srep00211","article-title":"Functionalized carboxyl nanoparticles enhance mucus dispersion and hydration","volume":"2","author":"Chen","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.114021_b0930","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1021\/acs.biomac.8b00795","article-title":"Farnesylated Glycol Chitosan as a Platform for Drug Delivery: Synthesis, Characterization, and Investigation of Mucus-Particle Interactions","volume":"19","author":"Ho","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2021.114021_b0935","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1023\/A:1016405126656","article-title":"Bioadhesion of lectin-latex conjugates to rat intestinal mucosa","volume":"13","author":"Irache","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.114021_b0940","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1097\/MIB.0000000000001010","article-title":"Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease","volume":"23","author":"Qin","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.addr.2021.114021_b0945","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/gutjnl-2018-317571","article-title":"Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis","volume":"68","author":"van der Post","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b0950","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.114021_b0955","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/ibd.20963","article-title":"PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease","volume":"15","author":"Zucchelli","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.addr.2021.114021_b0960","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2017.12.025","article-title":"Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice","volume":"148","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2021.114021_b0965","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.2147\/DDDT.S151725","article-title":"Regulation profile of the intestinal peptide transporter 1","volume":"11","author":"Wang","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.addr.2021.114021_b0970","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2007.10.026","article-title":"PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation","volume":"134","author":"Dalmasso","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b0975","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C9BM00925F","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2021.114021_b0980","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2005.03.013","article-title":"Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation","volume":"37","author":"Danese","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.addr.2021.114021_b0985","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(98)05050-8","article-title":"Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease","volume":"352","author":"Binion","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.114021_b0990","first-page":"G864","article-title":"Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro","volume":"263","author":"Kelly","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.addr.2021.114021_b0995","first-page":"4223","article-title":"Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice","volume":"7","author":"Mane","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.addr.2021.114021_b1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024202","article-title":"Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa","volume":"6","author":"Harel","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.114021_b1005","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1039\/c3tb21564d","article-title":"Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle","volume":"2","author":"Xiao","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2021.114021_b1010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.3700289","article-title":"Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation","volume":"85","author":"Kucharzik","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.addr.2021.114021_b1015","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00018-012-0963-z","article-title":"Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98","volume":"69","author":"Nguyen","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"1289\u20131300","key":"10.1016\/j.addr.2021.114021_b1020","first-page":"e1281","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b1025","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00042737-200310000-00007","article-title":"CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines","volume":"15","author":"Macdonald","year":"2003","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2021.114021_b1030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2559.1998.00404.x","article-title":"CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased crypt cell proliferation","volume":"32","author":"Fromont Hankard","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.addr.2021.114021_b1035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000068152","article-title":"Functional involvement of CD44 variant 7 in gut immune response","volume":"70","author":"Wittig","year":"2002","journal-title":"Pathobiology"},{"key":"10.1016\/j.addr.2021.114021_b1040","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2021.114021_b1045","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.34.7.865","article-title":"Inflammatory bowel disease\u2013a radical view","volume":"34","author":"Simmonds","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.addr.2021.114021_b1050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.114021_b1055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0891-5849(92)90079-V","article-title":"Oxygen radicals in ulcerative colitis","volume":"13","author":"Babbs","year":"1992","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.addr.2021.114021_b1060","doi-asserted-by":"crossref","unstructured":"L.B. Vong, T. Tomita, T. Yoshitomi, H. Matsui, Y. Nagasaki, An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice, Gastroenterology, 143 (2012) 1027-1036 e1023.","DOI":"10.1053\/j.gastro.2012.06.043"},{"key":"10.1016\/j.addr.2021.114021_b1065","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","article-title":"Nanotechnology intervention of the microbiome for cancer therapy","volume":"14","author":"Song","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2021.114021_b1070","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201905233","article-title":"Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis","volume":"16","author":"Ren","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.addr.2021.114021_b1075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41551-019-0423-2","article-title":"Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy","volume":"3","author":"Zheng","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2021.114021_b1080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2021.114021_b1085","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004529","article-title":"Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer","volume":"32","author":"Zheng","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2021.114021_b1090","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/acsanm.9b00439","article-title":"Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer","volume":"2","author":"Foulkes","year":"2019","journal-title":"ACS Applied Nano Materials"},{"key":"10.1016\/j.addr.2021.114021_b1095","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/hed.25492","article-title":"Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer","volume":"41","author":"Singh","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.addr.2021.114021_b1100","article-title":"Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel, Nat","author":"Han","year":"2021","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.addr.2021.114021_b1105","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.addr.2021.114021_b1110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41598-018-37143-z","article-title":"The gut microbiota heterogeneity and assembly changes associated with the IBD","volume":"9","author":"Sun","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.114021_b1115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.114021_b1120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.114021_b1125","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1038\/ajg.2010.281","article-title":"Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria","volume":"105","author":"Png","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.addr.2021.114021_b1130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000201045","article-title":"Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat","volume":"54","author":"Fabia","year":"1993","journal-title":"Digestion"},{"key":"10.1016\/j.addr.2021.114021_b1135","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.114021_b1140","first-page":"251","article-title":"Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice","volume":"28","author":"Bellavia","year":"2014","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.addr.2021.114021_b1145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ibd.20736","article-title":"Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa","volume":"15","author":"Llopis","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.addr.2021.114021_b1150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3920\/BM2016.0031","article-title":"A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production","volume":"8","author":"Kim","year":"2017","journal-title":"Benef Microbes"},{"key":"10.1016\/j.addr.2021.114021_b1155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2015.04.004","article-title":"Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp. lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice","volume":"26","author":"Kawahara","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2021.114021_b1160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6750-3-15","article-title":"In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii","volume":"3","author":"Ricci","year":"2003","journal-title":"BMC Biotech."},{"key":"10.1016\/j.addr.2021.114021_b1165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","article-title":"Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota","volume":"24","author":"Teng","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2021.114021_b1170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2021.114021_b1175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b1180","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2015.03.096","article-title":"Advances and challenges in mucosal adjuvant technology","volume":"33","author":"Newsted","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2021.114021_b1190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1195","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is mucosal tolerance a barrier?","volume":"179","author":"Mestecky","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b1200","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.4049\/jimmunol.1301181","article-title":"Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo","volume":"191","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b1205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.imlet.2014.07.006","article-title":"The effects of rapamycin on regulatory T cells: its potential time-dependent role in inducing transplant tolerance","volume":"162","author":"Shan","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2021.114021_b1210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2018.00230","article-title":"Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance","volume":"9","author":"Kishimoto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b1215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jconrel.2012.02.006","article-title":"Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery","volume":"160","author":"Devriendt","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.114021_b1220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1574-695X.2007.00359.x","article-title":"M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis","volume":"52","author":"Corr","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2021.114021_b1225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.imlet.2005.03.020","article-title":"Targeting antigens to murine and human M-cells with Aleuria aurantia lectin-functionalized microparticles","volume":"100","author":"Roth-Walter","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2021.114021_b1230","doi-asserted-by":"crossref","unstructured":"M. Garinot, V. Fievez, V. Pourcelle, F. Stoffelbach, A. des Rieux, L. Plapied, I. Theate, H. Freichels, C. Jerome, J. Marchand-Brynaert, Y.J. Schneider, V. Preat, PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination, J Control Release, 120 (2007) 195-204.","DOI":"10.1016\/j.jconrel.2007.04.021"},{"key":"10.1016\/j.addr.2021.114021_b1235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6750-12-7","article-title":"M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses","volume":"12","author":"Lo","year":"2012","journal-title":"BMC Biotech."},{"key":"10.1016\/j.addr.2021.114021_b1240","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.114021_b1245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/intimm\/dxu061","article-title":"A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses","volume":"26","author":"Shima","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b1250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.colsurfb.2010.08.027","article-title":"Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization","volume":"82","author":"Gupta","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.addr.2021.114021_b1255","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/IAI.67.2.946-953.1999","article-title":"Human intestinal M cells display the sialyl Lewis A antigen","volume":"67","author":"Giannasca","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2021.114021_b1260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tibtech.2011.02.004","article-title":"Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines","volume":"29","author":"Demento","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.addr.2021.114021_b1265","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1023\/A:1016030202104","article-title":"Lectin-bearing polymerized liposomes as potential oral vaccine carriers","volume":"13","author":"Chen","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.114021_b1270","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1016\/j.vaccine.2007.05.029","article-title":"TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces","volume":"25","author":"Chabot","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1275","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.176.7.4275","article-title":"TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium","volume":"176","author":"Chabot","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.114021_b1280","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.114021_b1285","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2021.114021_b1290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/IR:33:1:083","article-title":"Effects of flagellin on innate and adaptive immunity","volume":"33","author":"Honko","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.addr.2021.114021_b1295","first-page":"141","article-title":"CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections","volume":"5","author":"Harandi","year":"2004","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.addr.2021.114021_b1300","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.vaccine.2005.06.001","article-title":"Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives","volume":"23","author":"Arigita","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1305","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2741\/s108","article-title":"Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination","volume":"2","author":"Irache","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.addr.2021.114021_b1310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.addr.2020.12.008","article-title":"Non-viral COVID-19 vaccine delivery systems","volume":"169","author":"Park","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b1315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","article-title":"Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study","volume":"20","author":"Liebowitz","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2021.114021_b1320","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(00)05185-0","article-title":"Pathways for self-tolerance and the treatment of autoimmune diseases","volume":"357","author":"Goodnow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.114021_b1325","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1972595","article-title":"Autoimmune diseases: the failure of self tolerance","volume":"248","author":"Sinha","year":"1990","journal-title":"Science"},{"issue":"Suppl 4","key":"10.1016\/j.addr.2021.114021_b1330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2516.2004.00993.x","article-title":"Inhibitors in haemophilia: clinical aspects","volume":"10","author":"Dimichele","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.addr.2021.114021_b1335","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.addr.2021.114021_b1340","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2008.06.019","article-title":"Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles","volume":"132","author":"Bowman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.114021_b1345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2005.03.009","article-title":"Preparation and characterization of biodegradable nanoparticles entrapping immunodominant peptide conjugated with PEG for oral tolerance induction","volume":"105","author":"Lee","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.114021_b1350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.114021_b1355","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1467-7652.2007.00259.x","article-title":"Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts\u2013oral administration protects against development of insulitis in non-obese diabetic mice","volume":"5","author":"Ruhlman","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2021.114021_b1360","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/j.vaccine.2011.07.077","article-title":"Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function","volume":"29","author":"Odumosu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1365","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1096\/fj.05-5134fje","article-title":"Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system","volume":"20","author":"Limaye","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2021.114021_b1370","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.vaccine.2010.04.005","article-title":"Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism","volume":"28","author":"Gong","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.114021_b1375","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.addr.2012.10.005","article-title":"Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells","volume":"65","author":"Kwon","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114021_b1380","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0143","article-title":"Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response","volume":"370","author":"Gilmartin","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.addr.2021.114021_b1385","unstructured":"Environmental Chemicals, the Human Microbiome, and Health Risk: A Research Strategy, Washington (DC), 2017."},{"key":"10.1016\/j.addr.2021.114021_b1390","doi-asserted-by":"crossref","first-page":"3831972","DOI":"10.1155\/2017\/3831972","article-title":"Exercise Modifies the Gut Microbiota with Positive Health Effects","volume":"2017","author":"Monda","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.addr.2021.114021_b1395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrgastro.2016.139","article-title":"The gut microbiota and gastrointestinal surgery","volume":"14","author":"Guyton","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2021.114021_b1400","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","article-title":"Gut microbes and the brain: paradigm shift in neuroscience","volume":"34","author":"Mayer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2021.114021_b1405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00018-012-1028-z","article-title":"Voices from within: gut microbes and the CNS","volume":"70","author":"Forsythe","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2021.114021_b1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2982.2006.00871.x","article-title":"Sensory transmission in the gastrointestinal tract","volume":"19","author":"Blackshaw","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.addr.2021.114021_b1415","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112358","article-title":"The Microbiota-Gut-Brain Axis and Alzheimer Disease. From Dysbiosis to Neurodegeneration: Focus on the Central Nervous System Glial Cells","volume":"10","author":"Giovannini","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.addr.2021.114021_b1420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.addr.2021.114021_b1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: Implications in Parkinson's disease","volume":"38","author":"Parashar","year":"2017","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21004142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21004142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:09:46Z","timestamp":1759208986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21004142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":284,"alternative-id":["S0169409X21004142"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.114021","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.114021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114021"}}